LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signaling

por Afsahi, Arya, Silvestri, Christopher M., Moore, Allyson E., Graham, Carly F., Bacchiochi, Kaylyn, St-Jean, Martine, Baker, Christopher L., Korneluk, Robert G., Beug, Shawn T., LaCasse, Eric C., Bramson, Jonathan L.
Publicado 2023